Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
LABT
Valuation N/A
Lakewood-Amedex Biotherapeutics Inc.
Price$0.78
Model IV—
P/IV—
Limited data — see page
LAFA
Valuation N/A
LaFayette Acquisition Corp.
Price$10.18
Model IV—
P/IV—
Limited data — see page
LAFAR
Valuation N/A
LaFayette Acquisition Corp.
Price$0.07
Model IV—
P/IV—
Limited data — see page
LAFAU
Valuation N/A
LaFayette Acquisition Corp.
Price$10.22
Model IV—
P/IV—
Limited data — see page
LAKE
Deeply undervalued
LAKELAND INDUSTRIES INC
Price$9.96
Model IV$34.48
P/IV0.31
Discount 71%
Return to IV: +246.4%
Market implies -24.8%/yr
vs model +15.0% · below model
LANV
Valuation N/A
Lanvin Group Holdings Ltd
Price$0.94
Model IV—
P/IV—
Limited data — see page
LARK
Valuation N/A
LANDMARK BANCORP INC
Price$31.16
Model IV—
P/IV—
Limited data — see page
LASE
Deeply overvalued
Laser Photonics Corp
Price$0.74
Model IV$0.40
P/IV2.13
Premium +86%
Return to IV: -46.3%
Market implies +10.5%/yr
vs model +18.8% · below model
LATA
Valuation N/A
Galata Acquisition Corp. II
Price$10.21
Model IV—
P/IV—
Limited data — see page
LATAU
Valuation N/A
Galata Acquisition Corp. II
Price$10.30
Model IV—
P/IV—
Limited data — see page
LATAW
Valuation N/A
Galata Acquisition Corp. II
Price$0.22
Model IV—
P/IV—
Limited data — see page
LAW
Deeply overvalued
CS Disco, Inc.
Price$4.42
Model IV$2.59
P/IV1.64
Premium +70%
Return to IV: -41.3%
Market implies +6.0%/yr
vs model +8.2% · in line
LAWR
Valuation N/A
Robot Consulting Co., Ltd.
Price$3.75
Model IV—
P/IV—
Limited data — see page
LBGJ
Deeply overvalued
Li Bang International Corp Inc.
Price$1.87
Model IV$1.34
P/IV1.61
Premium +40%
Return to IV: -28.6%
Market implies +6.8%/yr
vs model +2.0% · above model
LCCC
Valuation N/A
Lakeshore Acquisition III Corp.
Price$10.54
Model IV—
P/IV—
Limited data — see page
LCCCR
Valuation N/A
Lakeshore Acquisition III Corp.
Price$0.14
Model IV—
P/IV—
Limited data — see page
LCCCU
Valuation N/A
Lakeshore Acquisition III Corp.
Price$10.80
Model IV—
P/IV—
Limited data — see page
LCFY
Valuation N/A
Locafy Ltd
Price$1.74
Model IV—
P/IV—
Limited data — see page
LCFYW
Valuation N/A
Locafy Ltd
Price$6.65
Model IV—
P/IV—
Market implies +33.8%/yr
vs model +6.1% · above model
LCLN
Valuation N/A
Lincoln International, Inc.
Price$24.62
Model IV—
P/IV—
Limited data — see page
LCNB
Overvalued
LCNB CORP
Price$18.52
Model IV$15.24
P/IV1.12
Premium +22%
Return to IV: -17.7%
LCUT
Deeply undervalued
LIFETIME BRANDS, INC
Price$9.52
Model IV$15.58
P/IV0.56
Discount 39%
Return to IV: +63.7%
Market implies -8.1%/yr
vs model +2.0% · below model
LDDD
Valuation N/A
Longduoduo Co Ltd
Price$0.51
Model IV—
P/IV—
Market implies +23.4%/yr
LDI
Valuation N/A
loanDepot, Inc.
Price$0.56
Model IV—
P/IV—
Market implies -27.5%/yr
LDP
Valuation N/A
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc.
Price$19.17
Model IV—
P/IV—
Limited data — see page
LEDS
Deeply undervalued
SemiLEDs Corp
Price$2.23
Model IV$3.54
P/IV0.64
Discount 37%
Return to IV: +58.7%
Market implies +7.8%/yr
vs model +25.0% · below model
LEE
Valuation N/A
LEE ENTERPRISES, Inc
Price$7.61
Model IV—
P/IV—
Market implies +25.4%/yr
vs model +0.0% · above model
LEGT
Valuation N/A
Legato Merger Corp. III
Price$9.52
Model IV—
P/IV—
Limited data — see page
LENZ
Deeply overvalued
LENZ Therapeutics, Inc.
Price$3.65
Model IV$0.66
P/IV5.67
Premium +450%
Return to IV: -81.8%
Market implies +21.6%/yr
vs model +15.0% · above model
LESL
Valuation N/A
Leslie's, Inc.
Price$0.03
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +2.0% · below model
LEXX
Valuation N/A
Lexaria Bioscience Corp.
Price$3.32
Model IV—
P/IV—
Market implies +56.8%/yr
LFAC
Valuation N/A
Leapfrog Acquisition Corp
Price$10.08
Model IV—
P/IV—
Limited data — see page
LFACW
Valuation N/A
Leapfrog Acquisition Corp
Price$0.28
Model IV—
P/IV—
Limited data — see page
LFCR
Deeply overvalued
LIFECORE BIOMEDICAL, INC. DE
Price$6.45
Model IV$2.86
P/IV1.75
Premium +125%
Return to IV: -55.6%
Market implies +8.0%/yr
vs model +6.3% · in line
LFMD
Deeply undervalued
LifeMD, Inc.
Price$2.63
Model IV$5.34
P/IV0.80
Discount 51%
Return to IV: +103.0%
Market implies -9.6%/yr
vs model +20.2% · below model
LFS
Deeply overvalued
LEIFRAS Co., Ltd.
Price$2.21
Model IV$1.60
P/IV1.35
Premium +38%
Return to IV: -27.7%
Market implies +6.4%/yr
vs model +5.0% · in line
LFT
Fairly valued
Lument Finance Trust, Inc.
Price$5.17
Model IV$4.93
P/IV0.21
Premium +5%
Return to IV: -4.6%
LFVN
Overvalued
Lifevantage Corp
Price$6.00
Model IV$4.63
P/IV1.34
Premium +30%
Return to IV: -22.8%
Market implies +6.4%/yr
vs model +6.1% · in line
LFWD
Deeply undervalued
Lifeward Ltd.
Price$6.49
Model IV$41.32
P/IV0.17
Discount 84%
Return to IV: +536.6%
Market implies -38.7%/yr
vs model +38.6% · below model
LGCL
Valuation N/A
Lucas GC Ltd
Price$2.23
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +15.0% · below model
LGCY
Deeply undervalued
Legacy Education Inc.
Price$10.23
Model IV$17.09
P/IV0.65
Discount 40%
Return to IV: +67.0%
Market implies +9.6%/yr
vs model +25.0% · below model
LGHL
Valuation N/A
Lion Group Holding Ltd
Price$3.10
Model IV—
P/IV—
Limited data — see page
LGI
Valuation N/A
LAZARD GLOBAL TOTAL RETURN & INCOME FUND INC
Price$17.10
Model IV—
P/IV—
Limited data — see page
LGL
Deeply overvalued
LGL GROUP INC
Price$6.83
Model IV$1.57
P/IV4.54
Premium +336%
Return to IV: -77.0%
Market implies +8.0%/yr
vs model +14.1% · below model
LGN
Valuation N/A
Legence Corp.
Price$51.53
Model IV—
P/IV—
Limited data — see page
LGO
Deeply overvalued
Largo Inc.
Price$0.47
Model IV$0.17
P/IV4.26
Premium +177%
Return to IV: -63.9%
Market implies +12.5%/yr
vs model +0.0% · above model
LGPS
Valuation N/A
LOGPROSTYLE INC.
Price$0.73
Model IV—
P/IV—
Market implies +33.2%/yr
vs model +8.0% · above model
LHAI
Deeply overvalued
Linkhome Holdings Inc.
Price$1.01
Model IV$0.76
P/IV1.21
Premium +33%
Return to IV: -25.0%
Market implies +19.1%/yr
vs model +25.0% · below model
LHSW
Valuation N/A
Lianhe Sowell International Group Ltd
Price$0.52
Model IV—
P/IV—
Market implies -50.0%/yr
LICN
Valuation N/A
Lichen International Ltd
Price$0.95
Model IV—
P/IV—
Market implies +34.8%/yr
vs model +2.0% · above model
LIDR
Valuation N/A
AEye, Inc.
Price$1.04
Model IV—
P/IV—
Market implies +43.0%/yr
vs model +8.0% · above model
LIDRW
Valuation N/A
LIDRW
Price$0.00
Model IV—
P/IV—
Limited data — see page
LIEN
Valuation N/A
Chicago Atlantic BDC, Inc.
Price$9.27
Model IV—
P/IV—
Limited data — see page
LIMN
Valuation N/A
Liminatus Pharma, Inc.
Price$3.76
Model IV—
P/IV—
Limited data — see page
LIMNW
Valuation N/A
Liminatus Pharma, Inc.
Price$0.05
Model IV—
P/IV—
Limited data — see page
LINK
Deeply overvalued
INTERLINK ELECTRONICS INC
Price$4.95
Model IV$1.38
P/IV3.90
Premium +259%
Return to IV: -72.2%
Market implies +17.8%/yr
vs model +12.3% · above model
LIQT
Deeply overvalued
LIQTECH INTERNATIONAL INC
Price$0.41
Model IV$0.28
P/IV2.49
Premium +47%
Return to IV: -32.0%
Market implies -0.8%/yr
vs model +2.0% · in line
LITS
Valuation N/A
Lite Strategy, Inc.
Price$1.27
Model IV—
P/IV—
Market implies -20.5%/yr
vs model +15.0% · below model
LIVE
Deeply undervalued
LIVE VENTURES Inc
Price$7.65
Model IV$80.07
P/IV0.13
Discount 90%
Return to IV: +946.7%
Market implies -32.5%/yr
vs model +11.5% · below model
LIXT
Valuation N/A
LIXT
Price$3.66
Model IV—
P/IV—
Limited data — see page
